LGALS2 and invasive breast carcinoma: Based on these findings, combined with the previous results related to immune infiltration T cells and its association with LGALS2 expression, we speculated that LGALS2 might be closely associated with immunotherapy outcome and contribute to immune response in BRCA patients.